News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Twenty-five states and DC sued to block DHS from withholding disaster grants tied to new election administration conditions, filing in Rhode Island.
  • Plaintiffs argue DHS and FEMA exceeded authority and intruded on state control of federal election administration ahead of the November midterms.
  • Trump's 2025 financial disclosures show more than $1.4 billion from family crypto ventures, including about $800 million from World Liberty Financial.
  • Disclosures also list roughly $635 million from sales of Trump-branded meme coins, shifting reported income toward digital assets.
  • Canada warned it will retaliate if the U.S. imposes a threatened 50% tariff by Aug. 19, reviving the prospect of cross-border trade measures.
  • Johnson Outdoors will report fiscal 2026 third-quarter results on Aug. 7 before market open and will host a conference call.

Latest Articles

Marvell Technology Executive Sells Shares Amid Strong AI Sector Optimism

Marvell Technology Executive Sells Shares Amid Strong AI Sector Optimism

Chris Koopmans, President and Chief Operating Officer at Marvell Technology, Inc., executed a sale of company stock totaling $2.06 million on June 1, 2026. This transaction occurred while the company's stock was trading near its 52-week high. Despite the executive selling shares, recent analyst reports have maintained or increased price targets for…

Asia Markets Edge Lower as Middle East Uncertainty Offsets AI-Driven Optimism

Asia Markets Edge Lower as Middle East Uncertainty Offsets AI-Driven Optimism

Asian stocks began Tuesday trading cautiously as conflicting signals from the Middle East tempered gains linked to renewed optimism around artificial intelligence. Major regional benchmarks swung between gains and losses, with MSCI’s Asia-Pacific ex-Japan index last 0.5% lower and Korean stocks falling about 2% after an initially firmer open. Marke…

Fitch to Remove Fonterra Ratings After Co-op Ends Engagement

Fitch to Remove Fonterra Ratings After Co-op Ends Engagement

Fitch Ratings has announced plans to withdraw its credit ratings on Fonterra Co-operative Group after the New Zealand dairy co-operative said it would cease engagement with the agency. Fitch intends to remove its international Long-Term Issuer Default Rating of 'A' and the 'A' rating on senior unsecured notes on or about July 1, citing commercial r…

Tribeca Strategic Acquisition Corp. Raises $140 Million in Nasdaq IPO

Tribeca Strategic Acquisition Corp. Raises $140 Million in Nasdaq IPO

Tribeca Strategic Acquisition Corp. completed an initial public offering of 14 million units at $10.00 per unit, generating $140 million in gross proceeds and began trading on the Nasdaq Global Market on May 29, 2026. A concurrent private placement of 470,000 units added $4.7 million, and the combined proceeds resulted in $140.35 million held in tr…

Evommune Executive Activity and Recent Corporate Milestones Under Scrutiny

Evommune Executive Activity and Recent Corporate Milestones Under Scrutiny

Gregory S. Moss, Chief Business & Legal Officer at Evommune, Inc., executed a significant sale of company shares while simultaneously acquiring additional stock through employee option exercises. This insider activity occurred as the company prepares for its earnings report on June 10th. Recent developments include the firm reporting a first-quarte…

Analysis of Insider Activity and Financial Developments at Evommune, Inc.

Analysis of Insider Activity and Financial Developments at Evommune, Inc.

The recent sale of shares by Evommune's CFO, Kyle Carver, provides an analytical snapshot of internal activity. The transaction occurred within a pre-arranged Rule 10b5-1 trading plan, while the company navigates both strong financial metrics and differing market valuation assessments. Furthermore, recent clinical trial progress and analyst upgrade…

Japan Evaluates Two-Year Food Sales Tax Reduction for 2027

Japan Evaluates Two-Year Food Sales Tax Reduction for 2027

The Japanese government is currently weighing a proposal to implement a two-year reduction on the consumption tax applied to food sales. According to reports citing an unnamed government executive, this potential policy change would involve lowering the current 8% levy on food items starting in April of next year. This move follows earlier commitme…

Dime Commercial Bank To Ring Opening Bell at New York Stock Exchange

Dime Commercial Bank To Ring Opening Bell at New York Stock Exchange

Dime Commercial Bancshares, Inc., the parent company of Dime Commercial Bank, will have its President and CEO Stuart H. Lubow ring the Opening Bell at the New York Stock Exchange on June 2, 2026. This event marks the bank's rebranding and name change to Dime Commercial Bank, effective the same day. The company emphasizes its strong position as the …

SEC Says Musk Settlement Is Product of Negotiation, Not Collusion

SEC Says Musk Settlement Is Product of Negotiation, Not Collusion

The U.S. Securities and Exchange Commission has defended a settlement with Elon Musk over the timing of his Twitter share disclosures, telling a federal court the agreement stemmed from negotiations between counsel and was not the product of improper collusion. The filing also noted a recent policy change that would permit Musk to publicly deny the…

Madrigal CMO Sells Shares Under Pre-Planned Trading Plan Amid Positive Clinical Data and Analyst Upgrades

Madrigal CMO Sells Shares Under Pre-Planned Trading Plan Amid Positive Clinical Data and Analyst Upgrades

David Soergel, the Chief Medical Officer at Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), recently sold a block of company shares. This transaction occurred despite recent positive developments for the firm, including robust quarterly earnings and significant clinical data presentations regarding its drug candidate, Rezdiffra.The sale involved 1,0…